BridgeBio Pharma is dedicated to developing breakthrough medicines for genetic diseases by bridging scientific advancements with commercial viability. The company focuses on treating underserved patient populations through innovative drug development and a commitment to fostering passionate, driven leaders in the field.
BridgeBio Pharma is seeking a Senior Director of Drug Safety and Pharmacovigilance to oversee the safety profile of a new negative allosteric modulator of the calcium-sensing receptor (CaSR) for autosomal dominant hypocalcemia type 1 (ADH1). They are developing a financial product for rare diseases and have received Orphan Drug Designation from the FDA. This role involves managing CROs, regulatory submissions, and ensuring compliance with safety standards.
BridgeBio Pharma is dedicated to developing breakthrough medicines for genetic diseases by bridging scientific advancements with commercial viability. The company focuses on treating underserved patient populations through innovative drug development and a commitment to fostering passionate, driven leaders in the field.
BridgeBio Pharma